Jane Street’s Vigil Neuroscience VIGL Stock Holding History

Jane Street’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,587	Closed	-$29.5K	–	11007
2025 Q1	$29.5K	Sell	16,587 -32,225	-66%	-$72.3K	﹤0.01%	9095
2024 Q4	$83K	Buy	+48,812	New	+$144K	﹤0.01%	8822
2024 Q3	–	Sell	-62,354	Closed	-$249K	–	10460
2024 Q2	$249K	Buy	+62,354	New	+$213K	﹤0.01%	8088
2024 Q1	–	Sell	-10,178	Closed	-$34.4K	–	10145
2023 Q4	$34.4K	Buy	+10,178	New	+$52.4K	﹤0.01%	8851
2023 Q2	–	Sell	-27,184	Closed	-$266K	–	9627
2023 Q1	$266K	Buy	+27,184	New	+$306K	﹤0.01%	7387

Other funds holding VIGL

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Jane Street's VIGL Position: Q2 2025 in Review

Jane Street sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 16,587 shares — an estimated $29.5K sold.

Jane Street first reported a position in VIGL in Q1 2023 and held it in 5 quarters. The position peaked at $266K in Q1 2023. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

Jane Street reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
Jane Street sold 16,587 Vigil Neuroscience shares in Q2 2025, an estimated $29.5K.
Jane Street first reported a position in Vigil Neuroscience in Q1 2023 and held it in 5 quarters.
Jane Street's Vigil Neuroscience position peaked at $266K in Q1 2023.
78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.